This innovative approach enhances biological screening for sEH PROTACs, suggesting faster drug discovery.
The Direct-to-Biology (D2B) approach enables biological screening of crude reaction mixtures, eliminating the need for purification steps and thereby accelerating drug discovery. In this study, we developed a miniaturized D2B...
No takes yet. Share an insight, caveat, or question.
Schoenfeld et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: